These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 16902803)
1. Hepatotoxin-induced hypertyrosinemia and its toxicological significance. Clayton TA; Lindon JC; Everett JR; Charuel C; Hanton G; Le Net JL; Provost JP; Nicholson JK Arch Toxicol; 2007 Mar; 81(3):201-10. PubMed ID: 16902803 [TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Beckwith-Hall BM; Nicholson JK; Nicholls AW; Foxall PJ; Lindon JC; Connor SC; Abdi M; Connelly J; Holmes E Chem Res Toxicol; 1998 Apr; 11(4):260-72. PubMed ID: 9548796 [TBL] [Abstract][Full Text] [Related]
3. Analysis of time-related metabolic fluctuations induced by ethionine in the rat. Skordi E; Yap IK; Claus SP; Martin FP; Cloarec O; Lindberg J; Schuppe-Koistinen I; Holmes E; Nicholson JK J Proteome Res; 2007 Dec; 6(12):4572-81. PubMed ID: 17966971 [TBL] [Abstract][Full Text] [Related]
4. Late preventive effects on dimethylnitrosamine, thioacetamide or galactosamine-induced liver necrosis of the inhibitor of proteases, phenylmethylsulfonyl fluoride. de Ferreyra EC; de Fenos OM; Castro JA Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):505-8. PubMed ID: 6665306 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of galactosamine toxicity revisited; a metabonomic study. Coen M; Hong YS; Clayton TA; Rohde CM; Pearce JT; Reily MD; Robertson DG; Holmes E; Lindon JC; Nicholson JK J Proteome Res; 2007 Jul; 6(7):2711-9. PubMed ID: 17580851 [TBL] [Abstract][Full Text] [Related]
6. Perfusion with picroliv reverses biochemical changes induced in livers of rats toxicated with galactosamine or thioacetamide. Dwivedi Y; Rastogi R; Garg NK; Dhawan BN Planta Med; 1993 Oct; 59(5):418-20. PubMed ID: 8255934 [TBL] [Abstract][Full Text] [Related]
7. Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status. Clayton TA; Lindon JC; Everett JR; Charuel C; Hanton G; Le Net JL; Provost JP; Nicholson JK Arch Toxicol; 2004 Feb; 78(2):86-96. PubMed ID: 14520508 [TBL] [Abstract][Full Text] [Related]
8. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Waters NJ; Waterfield CJ; Farrant RD; Holmes E; Nicholson JK Chem Res Toxicol; 2005 Apr; 18(4):639-54. PubMed ID: 15833024 [TBL] [Abstract][Full Text] [Related]
9. The potential use of cultured hepatocytes in predicting the hepatotoxicity of xenobiotics. Gómez-Lechón MJ; Montoya A; López P; Donato T; Larrauri A; Castell JV Xenobiotica; 1988 Jun; 18(6):725-35. PubMed ID: 3420948 [TBL] [Abstract][Full Text] [Related]
10. Late preventive effects of several anticalmodulin drugs on galactosamine-induced liver necrosis. de Ferreyra EC; de Fenos OM; Castro JA Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):289-92. PubMed ID: 3992011 [TBL] [Abstract][Full Text] [Related]
11. Effect of a load of Vitamin A after acute thioacetamide intoxication on dolichol, dolichol isoprenoids and retinol content in isolated rat liver cells. Bassi AM; Canepa C; Maloberti G; Casu A; Nanni G Toxicology; 2004 Jul; 199(2-3):97-107. PubMed ID: 15147784 [TBL] [Abstract][Full Text] [Related]
12. Heteronuclear 1H-31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: application to galactosamine-induced hepatotoxicity. Coen M; Hong YS; Cloarec O; Rhode CM; Reily MD; Robertson DG; Holmes E; Lindon JC; Nicholson JK Anal Chem; 2007 Dec; 79(23):8956-66. PubMed ID: 17973499 [TBL] [Abstract][Full Text] [Related]
13. Metabolic basis of hypertyrosinemia in liver disease. Andersson SM; Salaspuro M; Ohisalo JJ Gastroenterology; 1982 Mar; 82(3):554-7. PubMed ID: 6119273 [TBL] [Abstract][Full Text] [Related]
14. An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Clayton TA; Lindon JC; Everett JR; Charuel C; Hanton G; Le Net JL; Provost JP; Nicholson JK Arch Toxicol; 2003 Apr; 77(4):208-17. PubMed ID: 12698236 [TBL] [Abstract][Full Text] [Related]
15. Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis. Avni Y; Shirin H; Aeed H; Matas Z; Shahmurov M; Birkenfeld S; Bruck R J Med; 2003; 34(1-6):121-37. PubMed ID: 17682318 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy. Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832 [TBL] [Abstract][Full Text] [Related]
17. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Diaz-Buxo JA; Blumenthal S; Hayes D; Gores P; Gordon B Hepatology; 1997 Apr; 25(4):950-7. PubMed ID: 9096603 [TBL] [Abstract][Full Text] [Related]
19. Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Kang JS; Wanibuchi H; Morimura K; Wongpoomchai R; Chusiri Y; Gonzalez FJ; Fukushima S Toxicol Appl Pharmacol; 2008 May; 228(3):295-300. PubMed ID: 18374380 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the liver and plasma protein acute-phase response in mice by D-galactosamine. Koj A; Dubin A Br J Exp Pathol; 1976 Dec; 57(6):733-41. PubMed ID: 12781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]